Corporate Responsibility
June 23, 2023
Alnylam in the Community: CASPAR Partnership Highlight
Alnylam has partnered with community organization CASPAR (Cambridge And Somerville Programs for Addiction Recovery) for many years.
Read More ›
May 3, 2023
Building a Corporate Responsibility Program from the Ground Up: Key Learnings from Alnylam ...
If you are building your program or assessing your program, here are five key learnings which may be helpful to your organization
Read More ›
December 8, 2022
Alnylam Named One of America's Most Responsible Companies by Newsweek
Alnylam has been named one of America's Most Responsible Companies for 2023 by Newsweek and research firm Statista
Read More ›
June 20, 2022
Challenging Ourselves to Help Refugees: Supporting Refugees to Become Work-Ready
Alnylam has announced a three-year corporate partnership with Refugee Action, a United Kingdom (UK)-based charity dedicated to helping refugees...
Read More ›
March 16, 2022
Alnylam Publishes 2021 Corporate Responsibility Report
We're committed to taking bold actions that improve the health of humanity. Our 2021 Corporate Responsibility Report provides details on our progress...
Read More ›
December 21, 2021
Alnylam Publishes 2021 Patient Access Philosophy Report
Alnylam has published its 2021 Patient Access Philosophy Report detailing its actions as a company to provide access to its medicines for those who may...
Read More ›
October 13, 2021
Alnylam Challengers - a Health Equity Community Impact Program
Alnylam Challengers is Alnylam's signature CSR Community Impact Program. It aims to improve health access to underserved communities.
Read More ›
March 11, 2021
Alnylam Publishes First Corporate Responsibility Summary
Today, we've published Alnylam's first Corporate Responsibility Summary detailing our approach to corporate responsibility and the actions we are and intend...
Read More ›
December 7, 2020
Alnylam Releases 2nd Annual Patient Access Philosophy Report
The 2020 Alnylam Patient Access Philosophy Report details Alnylam's progress against key metrics related to patient access to its innovative RNAi therapeutics.
Read More ›
October 1, 2020
A New European Biotech Social Pact
The European Pact builds on Alnylam’s own pledge, encouraging biotech companies to be a force for good in partnering with European authorities, citizens and...
Read More ›
